Galderma Group AG ADR GALDY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $41.58
- Day Range
- $42.12–42.50
- 52-Week Range
- $33.13–46.31
- Bid/Ask
- $42.45 / $42.49
- Shares Outstanding
- 1.17B
- Market Cap
- $49.72B
- Volume/Avg
- 2,835 / 180,371
Key Statistics
- Price/Earnings (Normalized)
- 51.98
- Price/Sales
- 8.00
- Dividend Yield (Trailing)
- 0.21%
- Dividend Yield (Forward)
- 0.21%
- Dividend Payment Schedule
- May
- Total Yield
- 0.92%
Company Profile
Galderma was formed in 1981 as a joint venture between Nestle and L’Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a stand-alone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma’s science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 40% of net sales from the US and employs more than 7,500 people.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Growth
- Total Number of Employees
- 7,600
- Website
- https://www.galderma.com
Competitors
Valuation
|
Metric
|
GALDY
|
BEI
|
OR
|
|---|---|---|---|
Price/Earnings (Normalized) | 51.98 | 13.64 | 31.07 |
Price/Book Value | 5.71 | 1.93 | 6.09 |
Price/Sales | 8.00 | 1.81 | 4.57 |
Price/Cash Flow | 39.64 | 14.83 | 23.66 |
Price/Earnings
GALDY
BEI
OR
Financial Strength
|
Metric
|
GALDY
|
BEI
|
OR
|
|---|---|---|---|
Quick Ratio | 0.93 | 1.50 | 0.58 |
Current Ratio | 1.24 | 2.00 | 0.97 |
Interest Coverage | 6.84 | 42.97 | 19.89 |
Quick Ratio
GALDY
BEI
OR
Profitability
|
Metric
|
GALDY
|
BEI
|
OR
|
|---|---|---|---|
Return on Assets (Normalized) | 7.31% | 7.60% | 11.46% |
Return on Equity (Normalized) | 12.07% | 11.37% | 20.96% |
Return on Invested Capital (Normalized) | 10.17% | 10.80% | 15.09% |
Return on Assets
GALDY
BEI
OR
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|!Lz%p?dq | LOCK|hftHn | $70B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|HRGBnzKv | LOCK|^z!? | $49B | |||
| Haleon PLC ADR
HLN
| LOCK|mq%&!q@ | LOCK|@&f | $44B | |||
| Zoetis Inc Class A
ZTS
| LOCK|?l>%S>! | LOCK|zq | $32B | |||
| Viatris Inc
VTRS
| LOCK|>tl<dJ | LOCK|NMY | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|zf$ | LOCK|#Rq | $12B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|@VM$Lt | LOCK|P! | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|HQYn#pJ | LOCK|@hC | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|^D>X&#% | LOCK|H#<? | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|&&b?#p | LOCK|Vs | $2B |
United States